Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy is a research paper published in ACR Open Rheumatology (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: K23 HL150237
National Heart, Lung, and Blood Institute
Grant: U01 HL 60587
National Heart, Lung, and Blood Institute
Grant: U01 HL 60606
U.S. Department of Defense
Grant: W81XWH‐22‐1‐0162
NHLBI NIH HHS
Grant: U01 HL060587
NHLBI NIH HHS
Grant: U01 HL060606
National Institutes of Health
Grant: 5K23HL150237-05
Identifying predictors of treatment response in systemic sclerosis-related interstitial lung disease
National Institutes of Health
Grant: 5U01HL060606-05
SCLERODERMA LUNG STUDY
National Institutes of Health
Grant: 5U01HL060587-02
Scleroderma Lung Study
FWCI
2.08
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals